Delivery Order SPE2DB20D1110-SPE2DB25FK10A
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,255.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,927,117 units of Ondansetron ODT 8 mg tablets, with a performance period ending on April 16, 2025. This is a firm-fixed-price delivery order contract, and it is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $48,748.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,563,250,472 units of the drug Ondansetron ODT 4 mg tablet, with a performance period through January 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order contract valued at $18,768.35. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,742.47, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This federal contract award, valued at $13,852.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets and is a Firm Fixed Price Delivery Order with a completion date of January 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,513.29 firm fixed-price delivery order is for the supply of ondansetron ODT 8 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Delivery Order valued at $8,813.96, with a firm fixed price and an ultimate completion date of April 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,283.29 firm-fixed-price delivery order covers the supply of 4565734901 - Ondansetron ODT 4 mg Tablets, with a completion date of September 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,760.31 firm fixed-price delivery order contract is for the supply of 4564689893 Ondansetron ODT 4 mg tablets, with a completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...